5th Edition of International Heart Congress
June 24-26, 2027 | Hybrid Event
Myocardial Reperfusion
Myocardial reperfusion is a critical aspect of cardiovascular health, representing the restoration of blood flow to the heart muscle after a period of ischemia. Ischemia occurs when blood supply to the heart is temporarily reduced or blocked, often during a heart attack. Reperfusion aims to alleviate this condition and minimize damage to the heart tissue. However, the process itself can induce injury due to the sudden reintroduction of oxygen, leading to oxidative stress and inflammation. Researchers and healthcare professionals are continually exploring innovative strategies to optimize myocardial reperfusion, with a focus on minimizing adverse effects and enhancing overall cardiac recovery. Understanding the intricacies of myocardial reperfusion is crucial in advancing therapeutic approaches for cardiovascular diseases and improving patient outcomes.
John R Doty
Intermountain Medical Center, United States
Trevor Tucker
Dynamic Vascular Resolution Inc., Canada
Thomas J Webster
Brown University, United States
Uwe Peter Tigor
Auxilius Pharma, United States
Fatima Michelle Villa Jimenez
Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico
Mancilla Sandoval Yoana Tenneth
Instituto Nacional de Enfermedades Respiratorias "Ismael Cosío Villegas", Mexico
Sergey Suchkov
N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian FederationSubmit your abstract Today
Title : Healing a broken heart: One nano beat at a time
Thomas J Webster, Brown University, United States
Title : Surgical options for aortic valve preservation
John R Doty, Intermountain Medical Center, United States
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina